← Volver a la portada
Oceanía · Mercados regionales · The Motley Fool Australia

Why I'm not buying CBA shares but would sell everything to buy one ASX stock

Publicado por The Motley Fool Australia · Australia hace 5 h
Image source: Getty Images
Image source: Getty Images · The Motley Fool Australia

Resumen detallado

I think this stock could outperform the big four bank. The post Why I'm not buying CBA shares but would sell everything to buy one ASX stock appeared first on The Motley Fool…

There's a lot to like about Commonwealth Bank of Australia (ASX: CBA). It is an incredible business with a dominant market position and a history of delivering strong shareholder returns.

And if I had to choose just one ASX stock to put my money into instead, there's another company I'd much rather own.

My biggest issue with CBA is its valuation. The banking giant is currently trading on a forward PE ratio of approximately 25x. That's a huge premium for a mature bank with a relatively subdued earnings growth outlook.

Its recent trading update didn't convince me that this valuation is justified.

CBA reported quarterly cash earnings of approximately $2.8 billion, broadly flat on the second-half FY 2026 quarterly average.

With competition for mortgages and deposits remaining strong, alongside higher operating costs and credit losses, I struggle to see where the earnings growth needed to justify its premium will come from.

If CBA shares were 30% to 40% cheaper, I'd be loading up the truck. But at current levels, I'm happy to look elsewhere.

One ASX share I'd much rather put all my money into is sleep disorder treatment company ResMed Inc. (ASX: RMD).

I'm a big fan of this business and believe it has an excellent opportunity to continue growing its earnings at a strong rate for many years.

Inicio del artículo, extracto de The Motley Fool Australia. Para leer el resto, abra el artículo en el sitio del medio.

Leer el artículo completo en The Motley Fool Australia Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com.au)

También te puede interesar